-
1
-
-
84875474830
-
Iron deficiency in chronic heart failure: an international pooled analysis
-
e3
-
Klip IT, Comin-Colet J, Voors AA, Ponikowski P, Enjuanes C, Banasiak W, Lok DJ, Rosentryt P, Torrens A, Polonski L, van Veldhuisen DJ, van der Meer P, Jankowska EA. Iron deficiency in chronic heart failure: an international pooled analysis. Am Heart J 2013;165:575–582.e3.
-
(2013)
Am Heart J
, vol.165
, pp. 575-582
-
-
Klip, I.T.1
Comin-Colet, J.2
Voors, A.A.3
Ponikowski, P.4
Enjuanes, C.5
Banasiak, W.6
Lok, D.J.7
Rosentryt, P.8
Torrens, A.9
Polonski, L.10
van Veldhuisen, D.J.11
van der Meer, P.12
Jankowska, E.A.13
-
2
-
-
33845299533
-
Etiology of anemia in patients with advanced heart failure
-
Nanas JN, Matsouka C, Karageorgopoulos D, Leonti A, Tsolakis E, Drakos SG, Tsagalou EP, Maroulidis GD, Alexopoulos GP, Kanakakis JE, Anastasiou-Nana MI. Etiology of anemia in patients with advanced heart failure. J Am Coll Cardiol 2006;48:2485–2489.
-
(2006)
J Am Coll Cardiol
, vol.48
, pp. 2485-2489
-
-
Nanas, J.N.1
Matsouka, C.2
Karageorgopoulos, D.3
Leonti, A.4
Tsolakis, E.5
Drakos, S.G.6
Tsagalou, E.P.7
Maroulidis, G.D.8
Alexopoulos, G.P.9
Kanakakis, J.E.10
Anastasiou-Nana, M.I.11
-
3
-
-
84875205478
-
Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives
-
Jankowska EA, von Haehling S, Anker SD, Macdougall IC, Ponikowski P. Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives. Eur Heart J 2013;34:816–829.
-
(2013)
Eur Heart J
, vol.34
, pp. 816-829
-
-
Jankowska, E.A.1
von Haehling, S.2
Anker, S.D.3
Macdougall, I.C.4
Ponikowski, P.5
-
4
-
-
77955453008
-
Iron deficiency: an ominous sign in patients with systolic chronic heart failure
-
Jankowska EA, Rozentryt P, Witkowska A, Nowak J, Hartmann O, Ponikowska B, Borodulin-Nadzieja L, Banasiak W, Polonski L, Filippatos G, McMurray JJ, Anker SD, Ponikowski P. Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J 2010;31:1872–80.
-
(2010)
Eur Heart J
, vol.31
, pp. 1872-1880
-
-
Jankowska, E.A.1
Rozentryt, P.2
Witkowska, A.3
Nowak, J.4
Hartmann, O.5
Ponikowska, B.6
Borodulin-Nadzieja, L.7
Banasiak, W.8
Polonski, L.9
Filippatos, G.10
McMurray, J.J.11
Anker, S.D.12
Ponikowski, P.13
-
5
-
-
80155190205
-
Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure
-
Jankowska EA, Rozentryt P, Witkowska A, Nowak J, Hartmann O, Ponikowska B, Borodulin-Nadzieja L, von Haehling S, Doehner W, Banasiak W, Polonski L, Filippatos G, Anker SD, Ponikowski P. Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure. J Card Fail 2011;17:899–906.
-
(2011)
J Card Fail
, vol.17
, pp. 899-906
-
-
Jankowska, E.A.1
Rozentryt, P.2
Witkowska, A.3
Nowak, J.4
Hartmann, O.5
Ponikowska, B.6
Borodulin-Nadzieja, L.7
von Haehling, S.8
Doehner, W.9
Banasiak, W.10
Polonski, L.11
Filippatos, G.12
Anker, S.D.13
Ponikowski, P.14
-
6
-
-
84901244523
-
Iron deficiency and health-related quality of life in chronic heart failure: results from a multicenter European study
-
Enjuanes C, Klip IT, Bruguera J, Cladellas M, Ponikowski P, Banasiak W, van Veldhuisen DJ, van der Meer P, Jankowska EA, Comín-Colet J. Iron deficiency and health-related quality of life in chronic heart failure: results from a multicenter European study. Int J Cardiol 2014;174:268–275.
-
(2014)
Int J Cardiol
, vol.174
, pp. 268-275
-
-
Enjuanes, C.1
Klip, I.T.2
Bruguera, J.3
Cladellas, M.4
Ponikowski, P.5
Banasiak, W.6
van Veldhuisen, D.J.7
van der Meer, P.8
Jankowska, E.A.9
Comín-Colet, J.10
-
8
-
-
84908009638
-
Iron deficiency in a multi-ethnic Asian population with and without heart failure: prevalence, clinical correlates, functional significance and prognosis
-
Yeo TJ, Yeo PS, Ching-Chiew Wong R, Ong HY, Leong KT, Jaufeerally F, Sim D, Santhanakrishnan R, Lim SL, M Y Chan M, Chai P, Low AF, Ling LH, Ng TP, Richards AM, Lam CS. Iron deficiency in a multi-ethnic Asian population with and without heart failure: prevalence, clinical correlates, functional significance and prognosis. Eur J Heart Fail 2014;16:1125–1132.
-
(2014)
Eur J Heart Fail
, vol.16
, pp. 1125-1132
-
-
Yeo, T.J.1
Yeo, P.S.2
Ching-Chiew Wong, R.3
Ong, H.Y.4
Leong, K.T.5
Jaufeerally, F.6
Sim, D.7
Santhanakrishnan, R.8
Lim, S.L.9
M Y Chan, M.10
Chai, P.11
Low, A.F.12
Ling, L.H.13
Ng, T.P.14
Richards, A.M.15
Lam, C.S.16
-
9
-
-
84875207643
-
Iron status in patients with chronic heart failure
-
Jankowska EA, Malyszko J, Ardehali H, Koc-Zorawska E, Banasiak W, von Haehling S, Macdougall IC, Weiss G, McMurray JJ, Anker SD, Gheorghiade M, Ponikowski P. Iron status in patients with chronic heart failure. Eur Heart J 2013;34:827–834.
-
(2013)
Eur Heart J
, vol.34
, pp. 827-834
-
-
Jankowska, E.A.1
Malyszko, J.2
Ardehali, H.3
Koc-Zorawska, E.4
Banasiak, W.5
von Haehling, S.6
Macdougall, I.C.7
Weiss, G.8
McMurray, J.J.9
Anker, S.D.10
Gheorghiade, M.11
Ponikowski, P.12
-
10
-
-
84859059635
-
Iron supplementation for the treatment of chronic heart failure and iron deficiency: systematic review and meta-analysis
-
Avni T, Leibovici L, Gafter-Gvili A. Iron supplementation for the treatment of chronic heart failure and iron deficiency: systematic review and meta-analysis. Eur J Heart Fail 2012;14:423–429.
-
(2012)
Eur J Heart Fail
, vol.14
, pp. 423-429
-
-
Avni, T.1
Leibovici, L.2
Gafter-Gvili, A.3
-
11
-
-
84876743344
-
Outcomes of patients with chronic heart failure and iron deficiency treated with intravenous iron: a meta-analysis
-
Kapoor M, Schleinitz MD, Gemignani A, Wu WC. Outcomes of patients with chronic heart failure and iron deficiency treated with intravenous iron: a meta-analysis. Cardiovasc Hematol Disord Drug Targets 2013;13:35–44.
-
(2013)
Cardiovasc Hematol Disord Drug Targets
, vol.13
, pp. 35-44
-
-
Kapoor, M.1
Schleinitz, M.D.2
Gemignani, A.3
Wu, W.C.4
-
12
-
-
84888073074
-
Relation of respiratory muscle strength, cachexia and survival in severe chronic heart failure
-
Habedank D, Meyer FJ, Hetzer R, Anker SD, Ewert R. Relation of respiratory muscle strength, cachexia and survival in severe chronic heart failure. J Cachexia Sarcopenia Muscle 2013;4:277–285.
-
(2013)
J Cachexia Sarcopenia Muscle
, vol.4
, pp. 277-285
-
-
Habedank, D.1
Meyer, F.J.2
Hetzer, R.3
Anker, S.D.4
Ewert, R.5
-
13
-
-
84951557362
-
Skeletal myopathy in patients with chronic heart failure: significance of anabolic–androgenic hormones
-
Josiak K, Jankowska EA, Piepoli MF, Banasiak W, Ponikowski P. Skeletal myopathy in patients with chronic heart failure: significance of anabolic–androgenic hormones. J Cachexia Sarcopenia Muscle 2014;5:287–296.
-
(2014)
J Cachexia Sarcopenia Muscle
, vol.5
, pp. 287-296
-
-
Josiak, K.1
Jankowska, E.A.2
Piepoli, M.F.3
Banasiak, W.4
Ponikowski, P.5
-
14
-
-
84951560723
-
Ventricular assist device implantation improves skeletal muscle function, oxidative capacity, and growth hormone/insulin-like growth factor-1 axis signaling in patients with advanced heart failure
-
Khawaja T, Chokshi A, Ji R, Kato TS, Xu K, Zizola C, Wu C, Forman DE, Ota T, Kennel P, Takayama H, Naka Y, George I, Mancini D, Schulze CP. Ventricular assist device implantation improves skeletal muscle function, oxidative capacity, and growth hormone/insulin-like growth factor-1 axis signaling in patients with advanced heart failure. J Cachexia Sarcopenia Muscle 2014;5:297–305.
-
(2014)
J Cachexia Sarcopenia Muscle
, vol.5
, pp. 297-305
-
-
Khawaja, T.1
Chokshi, A.2
Ji, R.3
Kato, T.S.4
Xu, K.5
Zizola, C.6
Wu, C.7
Forman, D.E.8
Ota, T.9
Kennel, P.10
Takayama, H.11
Naka, Y.12
George, I.13
Mancini, D.14
Schulze, C.P.15
-
15
-
-
84901986431
-
The additive burden of iron deficiency in the cardiorenal–anaemia axis: scope of a problem and its consequences
-
Klip IT, Jankowska EA, Enjuanes C, Voors AA, Banasiak W, Bruguera J, Rozentryt P, Polonski L, van Veldhuisen DJ, Ponikowski P, Comin-Colet J, van der Meer P. The additive burden of iron deficiency in the cardiorenal–anaemia axis: scope of a problem and its consequences. Eur J Heart Fail 2014;16:655–662.
-
(2014)
Eur J Heart Fail
, vol.16
, pp. 655-662
-
-
Klip, I.T.1
Jankowska, E.A.2
Enjuanes, C.3
Voors, A.A.4
Banasiak, W.5
Bruguera, J.6
Rozentryt, P.7
Polonski, L.8
van Veldhuisen, D.J.9
Ponikowski, P.10
Comin-Colet, J.11
van der Meer, P.12
-
16
-
-
84890044082
-
Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial
-
Filippatos G, Farmakis D, Colet JC, Dickstein K, Lüscher TF, Willenheimer R, Parissis J, Gaudesius G, Mori C, von Eisenhart Rothe B, Greenlaw N, Ford I, Ponikowski P, Anker SD. Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial. Eur J Heart Fail 2013;15:1267–1276.
-
(2013)
Eur J Heart Fail
, vol.15
, pp. 1267-1276
-
-
Filippatos, G.1
Farmakis, D.2
Colet, J.C.3
Dickstein, K.4
Lüscher, T.F.5
Willenheimer, R.6
Parissis, J.7
Gaudesius, G.8
Mori, C.9
von Eisenhart, R.B.10
Greenlaw, N.11
Ford, I.12
Ponikowski, P.13
Anker, S.D.14
-
17
-
-
84879482070
-
The effect of intravenous ferric carboxymaltose on red cell distribution width: a subanalysis of the FAIR-HF study
-
Van Craenenbroeck EM, Conraads VM, Greenlaw N, Gaudesius G, Mori C, Ponikowski P, Anker SD. The effect of intravenous ferric carboxymaltose on red cell distribution width: a subanalysis of the FAIR-HF study. Eur J Heart Fail 2013;15:756–762.
-
(2013)
Eur J Heart Fail
, vol.15
, pp. 756-762
-
-
Van Craenenbroeck, E.M.1
Conraads, V.M.2
Greenlaw, N.3
Gaudesius, G.4
Mori, C.5
Ponikowski, P.6
Anker, S.D.7
-
18
-
-
35248870765
-
Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency
-
Toblli JE, Lombraña A, Duarte P, Di Gennaro F. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. J Am Coll Cardiol 2007;50:1657–1665.
-
(2007)
J Am Coll Cardiol
, vol.50
, pp. 1657-1665
-
-
Toblli, J.E.1
Lombraña, A.2
Duarte, P.3
Di Gennaro, F.4
-
19
-
-
37849053243
-
Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial
-
Okonko DO, Grzeslo A, Witkowski T, Mandal AK, Slater RM, Roughton M, Foldes G, Thum T, Majda J, Banasiak W, Missouris CG, Poole-Wilson PA, Anker SD, Ponikowski P. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial. J Am Coll Cardiol 2008;51:103–112.
-
(2008)
J Am Coll Cardiol
, vol.51
, pp. 103-112
-
-
Okonko, D.O.1
Grzeslo, A.2
Witkowski, T.3
Mandal, A.K.4
Slater, R.M.5
Roughton, M.6
Foldes, G.7
Thum, T.8
Majda, J.9
Banasiak, W.10
Missouris, C.G.11
Poole-Wilson, P.A.12
Anker, S.D.13
Ponikowski, P.14
-
20
-
-
84886283852
-
IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia
-
Beck-da-Silva L, Piardi D, Soder S, Rohde LE, Pereira-Barretto AC, de Albuquerque D, Bocchi E, Vilas-Boas F, Moura LZ, Montera MW, Rassi S, Clausell N. IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia. Int J Cardiol 2013;168:3439–3442.
-
(2013)
Int J Cardiol
, vol.168
, pp. 3439-3442
-
-
Beck-da-Silva, L.1
Piardi, D.2
Soder, S.3
Rohde, L.E.4
Pereira-Barretto, A.C.5
de Albuquerque, D.6
Bocchi, E.7
Vilas-Boas, F.8
Moura, L.Z.9
Montera, M.W.10
Rassi, S.11
Clausell, N.12
-
21
-
-
70350567772
-
A pilot evaluation of the long-term effect of combined therapy with intravenous iron sucrose and erythropoietin in elderly patients with advanced chronic heart failure and cardio-renal anemia syndrome: influence on neurohormonal activation and clinical outcomes
-
Comín-Colet J, Ruiz S, Cladellas M, Rizzo M, Torres A, Bruguera J. A pilot evaluation of the long-term effect of combined therapy with intravenous iron sucrose and erythropoietin in elderly patients with advanced chronic heart failure and cardio-renal anemia syndrome: influence on neurohormonal activation and clinical outcomes. J Card Fail 2009;15:727–735.
-
(2009)
J Card Fail
, vol.15
, pp. 727-735
-
-
Comín-Colet, J.1
Ruiz, S.2
Cladellas, M.3
Rizzo, M.4
Torres, A.5
Bruguera, J.6
-
22
-
-
72449156527
-
Ferric carboxymaltose in patients with heart failure and iron deficiency
-
Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H, Lüscher TF, Bart B, Banasiak W, Niegowska J, Kirwan BA, Mori C, von Eisenhart Rothe B, Pocock SJ, Poole-Wilson PA, Ponikowski P; FAIR-HF Trial Investigators. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 2009;361:2436–2448.
-
(2009)
N Engl J Med
, vol.361
, pp. 2436-2448
-
-
Anker, S.D.1
Comin Colet, J.2
Filippatos, G.3
Willenheimer, R.4
Dickstein, K.5
Drexler, H.6
Lüscher, T.F.7
Bart, B.8
Banasiak, W.9
Niegowska, J.10
Kirwan, B.A.11
Mori, C.12
von Eisenhart, R.B.13
Pocock, S.J.14
Poole-Wilson, P.A.15
Ponikowski, P.16
-
23
-
-
84925275800
-
Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency
-
Ponikowski P, van Veldhuisen DJ, Comin-Colet J, Ertl G, Komajda M, Mareev V, McDonagh T, Parkhomenko A, Tavazzi L, Levesque V, Mori C, Roubert B, Filippatos G, Ruschitzka F, Anker SD; CONFIRM-HF Investigators. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency. Eur Heart J 2015;36:657–668.
-
(2015)
Eur Heart J
, vol.36
, pp. 657-668
-
-
Ponikowski, P.1
van Veldhuisen, D.J.2
Comin-Colet, J.3
Ertl, G.4
Komajda, M.5
Mareev, V.6
McDonagh, T.7
Parkhomenko, A.8
Tavazzi, L.9
Levesque, V.10
Mori, C.11
Roubert, B.12
Filippatos, G.13
Ruschitzka, F.14
Anker, S.D.15
-
24
-
-
0034922729
-
EQ-5D: a measure of health status from the EuroQol Group
-
Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001;33:337–343.
-
(2001)
Ann Med
, vol.33
, pp. 337-343
-
-
Rabin, R.1
de Charro, F.2
-
25
-
-
0034039691
-
Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure
-
Green CP, Porter CB, Bresnahan DR, Spertus JA. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J Am Coll Cardiol 2000;35:1245–1255.
-
(2000)
J Am Coll Cardiol
, vol.35
, pp. 1245-1255
-
-
Green, C.P.1
Porter, C.B.2
Bresnahan, D.R.3
Spertus, J.A.4
-
26
-
-
84971242992
-
Patients' self-assessment of their congestive heart failure, part 2: content, reliability and validity of a new measure, the Minnesota Living with Heart Failure Questionnaire
-
Rector TS, Kubo SH, Cohn JN. Patients' self-assessment of their congestive heart failure, part 2: content, reliability and validity of a new measure, the Minnesota Living with Heart Failure Questionnaire. Heart Fail 1987;198–209.
-
(1987)
Heart Fail
, vol.198-209
-
-
Rector, T.S.1
Kubo, S.H.2
Cohn, J.N.3
-
27
-
-
84859001212
-
Cochrane Statistical Methods Group. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
-
Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA; Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928.
-
(2011)
BMJ
, vol.343
, pp. d5928
-
-
Higgins, J.P.1
Altman, D.G.2
Gøtzsche, P.C.3
Jüni, P.4
Moher, D.5
Oxman, A.D.6
Savovic, J.7
Schulz, K.F.8
Weeks, L.9
Sterne, J.A.10
-
29
-
-
0037098199
-
Quantifying heterogeneity in a meta-analysis
-
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539–1558.
-
(2002)
Stat Med
, vol.21
, pp. 1539-1558
-
-
Higgins, J.P.1
Thompson, S.G.2
-
31
-
-
0014384810
-
Report of a WHO scientific group
-
Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser 1968;405:5–37.
-
(1968)
World Health Organ Tech Rep Ser
, vol.405
, pp. 5-37
-
-
-
32
-
-
84879467972
-
EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot)
-
Maggioni AP, Dahlström U, Filippatos G, Chioncel O, Crespo Leiro M, Drozdz J, Fruhwald F, Gullestad L, Logeart D, Fabbri G, Urso R, Metra M, Parissis J, Persson H, Ponikowski P, Rauchhaus M, Voors AA, Nielsen OW, Zannad F, Tavazzi L; Heart Failure Association of the European Society of Cardiology (HFA). EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot). Eur J Heart Fail 2013;15:808–817.
-
(2013)
Eur J Heart Fail
, vol.15
, pp. 808-817
-
-
Maggioni, A.P.1
Dahlström, U.2
Filippatos, G.3
Chioncel, O.4
Crespo Leiro, M.5
Drozdz, J.6
Fruhwald, F.7
Gullestad, L.8
Logeart, D.9
Fabbri, G.10
Urso, R.11
Metra, M.12
Parissis, J.13
Persson, H.14
Ponikowski, P.15
Rauchhaus, M.16
Voors, A.A.17
Nielsen, O.W.18
Zannad, F.19
Tavazzi, L.20
more..
-
34
-
-
85018709433
-
Improving care for patients with acute heart failure: before, during and after hospitalization
-
Cowie MR, Anker SD, Cleland JG, Felker GM, Filippatos F, Jaarsma T, Jourdain P, Knight E, Massie B, Ponikowski P, López-Sendón J. Improving care for patients with acute heart failure: before, during and after hospitalization. ESC Heart Fail 2014;1:110–145.
-
(2014)
ESC Heart Fail
, vol.1
, pp. 110-145
-
-
Cowie, M.R.1
Anker, S.D.2
Cleland, J.G.3
Felker, G.M.4
Filippatos, F.5
Jaarsma, T.6
Jourdain, P.7
Knight, E.8
Massie, B.9
Ponikowski, P.10
López-Sendón, J.11
-
35
-
-
85003607197
-
Heart failure: preventing disease and death worldwide
-
Ponikowski P, Anker SD, AlHabib KF, Cowie MR, Force TL, Hu S, Jaarsma T, Krum H, Rastogi V, Rohde LE, Samal UC, Shimokawa H, Siswanto BB, Karen Sliwa K, Filippatos G. Heart failure: preventing disease and death worldwide. ESC Heart Faile 2014;1:4–25.
-
(2014)
ESC Heart Faile
, vol.1
, pp. 4-25
-
-
Ponikowski, P.1
Anker, S.D.2
AlHabib, K.F.3
Cowie, M.R.4
Force, T.L.5
Hu, S.6
Jaarsma, T.7
Krum, H.8
Rastogi, V.9
Rohde, L.E.10
Samal, U.C.11
Shimokawa, H.12
Siswanto, B.B.13
Karen Sliwa, K.14
Filippatos, G.15
-
36
-
-
49849088979
-
Anemia and mortality in heart failure patients a systematic review and meta-analysis
-
Groenveld HF, Januzzi JL, Damman K, van Wijngaarden J, Hillege HL, van Veldhuisen DJ, van der Meer P. Anemia and mortality in heart failure patients a systematic review and meta-analysis. J Am Coll Cardiol 2008;52:818–227.
-
(2008)
J Am Coll Cardiol
, vol.52
, pp. 227-818
-
-
Groenveld, H.F.1
Januzzi, J.L.2
Damman, K.3
van Wijngaarden, J.4
Hillege, H.L.5
van Veldhuisen, D.J.6
van der Meer, P.7
-
37
-
-
84862578773
-
Anemia in chronic heart failure: can we treat? What to treat?
-
von Haehling S, Anker MS, Jankowska EA, Ponikowski P, Anker SD. Anemia in chronic heart failure: can we treat? What to treat? Heart Fail Rev 2012;17:203–210.
-
(2012)
Heart Fail Rev
, vol.17
, pp. 203-210
-
-
von Haehling, S.1
Anker, M.S.2
Jankowska, E.A.3
Ponikowski, P.4
Anker, S.D.5
-
38
-
-
84875500204
-
Treatment of anemia with darbepoetin alfa in systolic heart failure
-
Swedberg K, Young JB, Anand IS, Cheng S, Desai AS, Diaz R, Maggioni AP, McMurray JJ, O'Connor C, Pfeffer MA, Solomon SD, Sun Y, Tendera M, van Veldhuisen DJ; RED-HF Committees; RED-HF Investigators. Treatment of anemia with darbepoetin alfa in systolic heart failure. N Engl J Med 2013;368:1210–1219.
-
(2013)
N Engl J Med RED-HF Investigators
, vol.368
, pp. 1210-1219
-
-
Swedberg, K.1
Young, J.B.2
Anand, I.S.3
Cheng, S.4
Desai, A.S.5
Diaz, R.6
Maggioni, A.P.7
McMurray, J.J.8
O'Connor, C.9
Pfeffer, M.A.10
Solomon, S.D.11
Sun, Y.12
Tendera, M.13
van Veldhuisen, D.J.14
-
39
-
-
84978983816
-
Clinical trials update from the European Society of Cardiology meeting 2014: PARADIGM-HF, CONFIRM-HF, SIGNIFY, atrial fibrillation, beta-blockers and heart failure, and vagal stimulation in heart failure
-
Clark AL, Pellicori P. Clinical trials update from the European Society of Cardiology meeting 2014: PARADIGM-HF, CONFIRM-HF, SIGNIFY, atrial fibrillation, beta-blockers and heart failure, and vagal stimulation in heart failure. ESC Heart Fail 2014;1:82–86.
-
(2014)
ESC Heart Fail
, vol.1
, pp. 82-86
-
-
Clark, A.L.1
Pellicori, P.2
-
40
-
-
84908246200
-
High prevalence of iron deficiency in patients with acute decompensated heart failure
-
Cohen-Solal A, Damy T, Terbah M, Kerebel S, Baguet JP, Hanon O, Zannad F, Laperche T, Leclercq C, Concas V, Duvillié L, Darné B, Anker S, Mebazaa A. High prevalence of iron deficiency in patients with acute decompensated heart failure. Eur J Heart Fail 2014;16:984–991.
-
(2014)
Eur J Heart Fail
, vol.16
, pp. 984-991
-
-
Cohen-Solal, A.1
Damy, T.2
Terbah, M.3
Kerebel, S.4
Baguet, J.P.5
Hanon, O.6
Zannad, F.7
Laperche, T.8
Leclercq, C.9
Concas, V.10
Duvillié, L.11
Darné, B.12
Anker, S.13
Mebazaa, A.14
-
41
-
-
0025100849
-
The existence of publication bias and risk factors for its occurrence
-
Dickersin K. The existence of publication bias and risk factors for its occurrence. JAMA 1990;263:1385–1389.
-
(1990)
JAMA
, vol.263
, pp. 1385-1389
-
-
Dickersin, K.1
-
42
-
-
17944391767
-
Intravenous iron-dextran: therapeutic and experimental possibilities
-
Ganzoni AM. Intravenous iron-dextran: therapeutic and experimental possibilities. Schweiz Med Wochenschr 1970;100:301–303.
-
(1970)
Schweiz Med Wochenschr
, vol.100
, pp. 301-303
-
-
Ganzoni, A.M.1
-
43
-
-
68049122102
-
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement
-
Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. PLoS Med 2009;6:e1000097.
-
(2009)
PLoS Med
, vol.6
-
-
Moher, D.1
Liberati, A.2
Tetzlaff, J.3
Altman, D.G.4
|